首页> 外文期刊>Seminars in radiation oncology >Therapeutic targets in malignant glioblastoma microenvironment.
【24h】

Therapeutic targets in malignant glioblastoma microenvironment.

机译:恶性胶质母细胞瘤微环境中的治疗目标。

获取原文
获取原文并翻译 | 示例
           

摘要

There is considerable evidence that the tissue microenvironment can suppress cancer and that microenvironment disruption is required for cancer growth and progression. Distortion of the microenvironment by tumor cells can promote growth, recruit nonmalignant cells that provide physiological resources, and facilitate invasion. Compared with the variable routes taken by cells to become cancers, the response of normal tissue to cancer is relatively consistent such that controlling cancer may be more readily achieved indirectly via the microenvironment. Here, we discuss 3 ideas about how the microenvironment, consisting of a vasculature, inflammatory cells, immune cells, growth factors, and extracellular matrix, might provide therapeutic targets in glioblastoma (GBM) in the context of radiotherapy (RT): (1) viable therapeutic targets exist in the GBM microenvironment, (2) RT alters the microenvironment of tissues and tumors; and (3) a potential benefit may be achieved by targeting the microenvironments induced by RT.
机译:有大量证据表明组织微环境可以抑制癌症,并且微环境破坏是癌症生长和发展所必需的。肿瘤细胞对微环境的扭曲可以促进生长,募集提供生理资源的非恶性细胞,并促进入侵。与细胞变成癌症的可变途径相比,正常组织对癌症的反应相对一致,因此可以更容易地通过微环境间接控制癌症。在这里,我们讨论有关由微血管,炎症细胞,免疫细胞,生长因子和细胞外基质组成的微环境在放射疗法(RT)的背景下如何为胶质母细胞瘤(GBM)提供治疗靶点的3种想法:(1) GBM微环境中存在可行的治疗靶标;(2)RT改变了组织和肿瘤的微环境; (3)通过靶向RT诱导的微环境可以获得潜在的好处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号